Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
14.62 USD | +2.81% | +7.11% | +36.64% |
05-21 | Immunome Insider Bought Shares Worth $1,388,072, According to a Recent SEC Filing | MT |
05-20 | Immunome Completes Purchase of Antibodies From Atreca | MT |
End-of-day quotes
Compared values
Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
---|---|---|---|---|---|---|---|---|---|---|---|
IMMUNOME, INC. | Bio Therapeutic Drugs | +2.81% | +7.11% | +36.64% | +185.55% | - | 876M |
Technical Rankings Surperformance
- Stock Market
- Equities
- IMNM Stock
- Charts Immunome, Inc.
- Comparison Chart